DrugPatentWatch Database Preview

Details for Patent: 5,808,146

« Back to Dashboard

Which drugs does patent 5,808,146 protect, and when does it expire?

Patent 5,808,146 protects AXUMIN and is included in one NDA.

This patent has ten patent family members in five countries.

Summary for Patent: 5,808,146

Title:	Amino acid analogs for tumor imaging
Abstract:	The invention provides novel amino acid compounds of use in detecting and evaluating brain and body tumors. These compounds combine the advantageous properties of 1-amino-cycloalkyl-1-carboxylic acids, namely, their rapid uptake and prolonged retention in tumors with the properties of halogen substituents, including certain useful halogen isotopes including fluorine-18, iodine-123, iodine-125, iodine-131, bromine-75, bromine-76, bromine-77 and bromine-82. In one aspect, the invention features amino acid compounds that have a high specificity for target sites when administered to a subject in vivo. Preferred amino acid compounds show a target to non-target ratio of at least 5:1, are stable in vivo and substantially localized to target within 1 hour after administration. An especially preferred amino acid compound is [.sup.18 F]-1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC). In another aspect, the invention features pharmaceutical compositions comprised of an .alpha.-amino acid moiety attached to either a four, five, or a six member carbon-chain ring. In addition, the invention features analogs of .alpha.-aminoisobutyric acid.
Inventor(s):	Goodman; Mark M. (Atlanta, GA), Shoup; Timothy (Decatur, GA)
Assignee:	Emory University (Atlanta, GA)
Application Number:	08/554,906
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 5,808,146

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Blue Earth	AXUMIN	fluciclovine f-18	SOLUTION;INTRAVENOUS	208054-001	May 27, 2016		RX	Yes	Yes				Y

Non-Orange Book US Patents Family Members for Patent 5,808,146

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
5,817,776	Amino acid analogs for tumor imaging

International Family Members for US Patent 5,808,146

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	1120497
Australia	720738
Canada	2237218
European Patent Office	0862464